Aspira Women's Health Inc. AWHL

0.26 0.00 0.00% as of 25 Sep
Market cap
$2.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
2.33 1.09 4.22 4.56 28.90 145.39 15.46 6.89 32.86 21.74
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(10.85) (9.83) (11.19) (5.27) (25.73) (142.18) (24.44) (9.15) (47.65) (20.78)
P/B ratio
0.00 0.00 0.00 5.34 6.52 69.57 8.03 2.94 30.10 15.27
Price to Tangible BV
0.00 0.00 0.00 5.34 6.52 69.57 8.03 2.94 30.10 15.27
EV/Sales
2.33 1.13 4.18 3.36 23.98 142.83 13.24 4.31 31.62 20.46
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(3.06) (0.86) (2.41) (0.88) (5.96) (45.09) (4.63) (1.40) (12.14) (3.87)
EV/FCF
(3.05) (0.85) (2.40) (0.88) (5.92) (43.63) (4.59) (1.39) (12.05) (3.55)
Quick Ratio
0.85 0.50 0.79 2.63 4.87 2.92 3.17 3.42 2.20 2.15
Current Ratio
1.17 0.77 1.03 2.95 5.10 3.10 3.37 3.64 2.42 2.39
Net Debt/EBITDA
0.00 (0.02) 0.02 0.32 1.04 0.67 0.68 0.74 0.40 0.24
Debt/Assets
32.44% 38.63% 36.19% 20.04% 9.00% 24.14% 11.53% 12.98% 22.22% 23.06%
Debt/Equity
(0.26) (0.83) (0.96) 0.50 0.12 0.49 0.18 0.21 0.49 0.49
Asset Turnover
1.68 1.56 0.77 0.28 0.22 0.28 0.36 0.32 0.40 0.18
Operating CF/Net income
0.55 0.93 0.95 1.04 0.87 0.82 0.85 0.82 0.71 0.93
Capex/Depreciation
(3.58) (0.40) (0.12) (0.88) (0.61) (1.85) (0.40) (0.17) (0.08) (1.74)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
269.20% 531.42% (723.45%) (160.88%) (158.74%) (194.02%) (191.78%) (215.38%) (319.12%) (140.49%)
ROA
(233.49%) (222.82%) (141.23%) (102.25%) (104.35%) (107.11%) (120.76%) (120.30%) (147.45%) (103.30%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (2,532.86%)
Return on Tangible Assets
(1,981.40%) 1,076.81% (5,119.63%) (268.03%) (97.04%) (135.79%) (155.72%) (134.86%) (234.55%) (274.24%)
Average Days of Receivables
47.80 39.35 58.18 55.53 55.03 67.88 74.32 93.97 23.97 37.99
Research and Development Expense of Revenue
31.23% 35.57% 44.08% 72.30% 78.01% 45.24% 22.43% 18.02% 26.82% 82.21%
Selling, General and Administrative Expense of Revenue
118.82% 201.38% 219.35% 361.00% 445.43% 367.94% 340.57% 350.28% 314.35% 481.68%
Intangible Assets out of Total Assets
0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
5.76% 16.27% 18.83% 29.50% 51.95% 33.28% 26.29% 36.06% 46.11% 44.63%
Graham Net Nets
(0.39) (0.39) (0.09) 0.16 0.15 0.01 0.12 0.31 0.02 0.03
Graham Number
1.30 2.00 3.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(58.65%) (138.03%) (44.29%) (80.11%) (15.81%) (2.67%) (22.21%) (56.64%) (11.11%) (25.44%)
Free Cash Flow Yield
(32.80%) (121.07%) (41.24%) (83.93%) (14.01%) (2.25%) (18.66%) (45.07%) (7.99%) (26.50%)
Revenue per Share
0.27 0.65 0.99 1.05 0.92 0.69 0.79 0.65 0.82 0.76
Operating CF per Share
(0.21) (0.86) (1.72) (4.00) (3.69) (2.19) (2.24) (2.00) (2.14) (4.01)
Capex per Share
(0.01) 0.00 0.00 (0.03) (0.02) (0.07) (0.02) (0.02) (0.02) (0.36)
Free Cash Flow per Share
(0.22) (0.86) (1.72) (4.03) (3.72) (2.27) (2.27) (2.03) (2.16) (4.37)
Cash per Share
0.05 0.13 0.28 1.71 5.01 2.48 2.03 2.00 1.46 1.51
Shareholders Equity per Share
(0.20) (0.18) (0.26) 0.90 4.07 1.45 1.51 1.53 0.90 1.08
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.20) (0.18) (0.26) 0.90 4.07 1.45 1.51 1.53 0.90 1.08
Free Cash Flow
(7.43) (12.15) (15.92) (31.30) (27.58) (15.22) (13.10) (9.48) (8.19) (15.22)
Working Capital
0.60 (1.28) 0.16 10.78 32.17 12.60 9.43 7.82 3.70 3.55
Capital Expenditures
(0.40) (0.04) (0.02) (0.23) (0.18) (0.49) (0.13) (0.11) (0.06) (1.26)
Net Current Asset Value
(8.32) (3.87) (3.35) 5.92 29.10 8.72 8.32 6.53 2.22 1.85
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.04 0.00 0.00 0.03 0.03 0.11 0.03 0.04 0.02 0.48
Net Profit Margin
(138.67%) (142.61%) (182.32%) (365.16%) (464.80%) (384.97%) (335.76%) (372.45%) (366.52%) (566.54%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
2.38 1.33 1.21 0.72 0.65 0.45 0.94 1.11 0.67 0.38
Cash ROIC
207.69% (918.01%) (642.87%) (132.27%) (39.21%) (49.28%) (60.44%) (55.44%) (87.73%) (146.26%)
Accounts Receivable Turnover
8.39 7.50 6.77 7.20 7.20 5.20 5.31 6.16 13.00 14.60
Accounts Payable Turnover
1.94 2.16 3.63 3.24 2.88 3.49 3.70 3.71 3.58 2.89
Inventory Turnover
11.34 13.39 14.34 15.76 36.76 124.18 57.15 32.39 29.89 29.98
Average Days of Payables
136.78 214.19 118.26 83.29 146.10 117.89 93.35 110.36 93.32 119.19
Days of Inventory on Hand
28.31 32.13 21.29 29.87 16.94 3.21 2.73 10.69 12.78 12.58
Average Receivables
1.10 1.22 1.35 1.14 0.95 0.89 0.86 0.50 0.24 0.18
Average Payables
1.71 1.72 1.07 1.19 1.30 0.98 0.90 0.85 0.81 0.93
Average Inventory
0.29 0.28 0.27 0.25 0.10 0.03 0.06 0.10 0.10 0.09
Average Assets
5.47 5.88 11.82 29.23 30.34 16.72 12.62 9.45 7.76 14.49
Average Common Equity
(4.75) (2.46) 2.31 18.58 19.95 9.23 7.95 5.28 3.58 10.65

Fold the line items

Columns are period end dates